Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BTC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02386397
What this trial is testing

Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Digestive Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 66
Large-scale testing (Phase 3)Not Yet RecruitingNCT07437287
What this trial is testing

Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer (BTC)
UNICANCER 160
Testing effectiveness (Phase 2)UnknownNCT05653180
What this trial is testing

IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Innovent Biologics (Suzhou) Co. Ltd. 20
Large-scale testing (Phase 3)Looking for participantsNCT06037980
What this trial is testing

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
Gruppo Oncologico del Nord-Ovest 300
Not applicableLooking for participantsNCT07206355
What this trial is testing

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Cholangiocarcinoma+4 more
University of Nottingham 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06037655
What this trial is testing

Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC

Who this might be right for
Biliary Tract Neoplasms
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07635290
What this trial is testing

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Who this might be right for
Previously Treated, AdvancedBiliary Tract Cancers
West China Hospital 26
Testing effectiveness (Phase 2)Study completedNCT03314935
What this trial is testing

INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Who this might be right for
Biliary Tract Cancer (BTC)Colorectal Cancer (CRC)Endometrial Cancer+3 more
Incyte Corporation 149
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Testing effectiveness (Phase 2)WithdrawnNCT03768531
What this trial is testing

Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer

Who this might be right for
Resectable Biliary Tract Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06903273
What this trial is testing

Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBiliary Tract Cancer (BTC)
National Cheng-Kung University Hospital 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238637
What this trial is testing

Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06699459
What this trial is testing

Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC

Who this might be right for
Biliary Tract Carcinoma
Sir Run Run Shaw Hospital 76
Not applicableActive Not RecruitingNCT06975917
What this trial is testing

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

Who this might be right for
Biliary Tract CancerBiliary Tract Cancers (BTC)
Ankara University 600
Early research (Phase 1)Looking for participantsNCT06564623
What this trial is testing

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Who this might be right for
Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07638501
What this trial is testing

Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Eastern Hepatobiliary Surgery Hospital 123
Testing effectiveness (Phase 2)UnknownNCT01180153
What this trial is testing

Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)

Who this might be right for
Biliary Tract Cancer
Peking University Cancer Hospital & Institute 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07296666
What this trial is testing

Adjuvant Chemotherapy for BTC Based on 3D-PTA

Who this might be right for
Cholangiocarcinoma
Fudan University 98
Large-scale testing (Phase 3)Active Not RecruitingNCT03478488
What this trial is testing

Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC

Who this might be right for
Biliary Tract Neoplasms
3D Medicines (Sichuan) Co., Ltd. 480
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Next Page